EVC
AGN

Eidelman Virant Capital’s Allergan plc AGN Stock Holding History

Eidelman Virant Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,968
Closed -$1.52M – 137
2018
Q3 		$1.52M Buy
7,968
+120
+2% +$22K 0.74% 44
2018
Q2 		$1.31M Hold
7,848
– – 0.81% 41
2018
Q1 		$1.32M Sell
7,848
-2,145
-21% -$360K 0.86% 40
2017
Q4 		$1.63M Sell
9,993
-5,652
-36% -$1.01M 0.96% 37
2017
Q3 		$3.21M Sell
15,645
-520
-3% -$121K 1.91% 13
2017
Q2 		$3.93M Buy
+16,165
New +$3.8M 2.27% 11
2014
Q1 		– Sell
-3,200
Closed -$538K – 202
2013
Q4 		$538K Buy
+3,200
New +$500K 0.23% 96

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Eidelman Virant Capital's AGN Position: Q4 2018 in Review

Eidelman Virant Capital sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 7,968 shares — an estimated $1.52M sold.

Eidelman Virant Capital first reported a position in AGN in Q4 2013 and held it in 7 quarters. The position peaked at $3.93M in Q2 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Eidelman Virant Capital reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Eidelman Virant Capital sold 7,968 Allergan plc shares in Q4 2018, an estimated $1.52M.
  • Eidelman Virant Capital first reported a position in Allergan plc in Q4 2013 and held it in 7 quarters.
  • Eidelman Virant Capital's Allergan plc position peaked at $3.93M in Q2 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Eidelman Virant Capital's 13F filing for Q4 2018, filed 18 Jan 2019.